Merck & Co is to see whether its oral antifungal agent Noxafil (posaconazole) can be used in chronic cases of …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

